ARWR

Arrowhead Pharmaceuticals Inc.

Price

$86.67

return (12m)

450.60%

p/e

-40.50

p/bv

20.35

DIVIDEND YIELD

0.00%

ARWR price

Arrowhead Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARWR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.86%

3 months

17.75%

1 year

450.60%

2 years

207.43%

5 years

26.76%

10 years

1,354.11%

Fundamentals ARWR

Valuation

P/E

-40.50

Sector -4.03

Industry -4.03

P/BV

20.35

Sector 2.05

Industry 2.05

P/Revenue (PSR)

19.59

Sector -4.26

Industry -4.26

EV/EBITDA

-104.75

Sector -238.32

Industry -238.32

EV/EBIT

-98.89

Sector -670.55

Industry -670.55

P/EBITDA

-90.64

Sector -4.23

Industry -4.23

P/EBIT

-76.26

Sector -4.29

Industry -4.29

P/Total Assets

5.37

Sector 1.45

Industry 1.45

P/Ativo Circ. Liq.

71.53

Sector -11.51

Industry -11.51

P/Cap.Giro

7.89

Sector -11.45

Industry -11.45

EPS

-2.12

Sector -2.20

Industry -2.20

BVPS

4.22

Sector 1.95

Industry 1.95

Efficiency

Gross Margin

100.00%

Sector 36.28%

Industry 36.28%

EBITDA Margin

-145.58%

Sector -16,822.56%

Industry -16,822.56%

EBIT Margin

-154.22%

Sector -4,238,732.42%

Industry -4,238,732.42%

Operating Margin

-35.67%

Sector -38.78%

Industry -38.78%

Net Profit Margins

-48.38%

Sector -39.92%

Industry -39.92%

Giro Ativos

0.03

Sector 0.03

Industry 0.03

Profitability

ROE

-50.24%

Sector -65.93%

Industry -65.93%

ROA

-13.27%

Sector -66.10%

Industry -66.10%

ROIC

-94.49%

Sector -2,918.81%

Industry -2,918.81%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.23

Sector 2.91

Industry 2.91

Dívida Líquida/EBITDA

8.78

Sector -13,526,126.12

Industry -13,526,126.12

Dívida Líquida/EBIT

8.29

Sector -3.66

Industry -3.66

Dívida Líquida/Patrimônio

-1.57

Sector -1.10

Industry -1.10

Dívida Bruta/Patrimônio

1.41

Sector -0.10

Industry -0.10

Equity/Assets

0.26

Sector 0.42

Industry 0.42

Liabilities/Assets

0.74

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

33.92%

Sector -

Industry -

5Y Earnings CAGR

10.46%

Sector -

Industry -

Fundamentals ARWR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
ARWR	-40.50	20.35	-50.24%	0.00%	$12.19 B	-48.38%
JNJ	30.06	7.44	24.76%	1.99%	$632.34 B	21.48%
PFE	18.39	1.52	8.29%	7.11%	$137.74 B	11.83%
ABBV	126.05	-69.30	-54.98%	2.60%	$458.19 B	5.79%
NVO	11.48	6.93	60.40%	3.79%	$217.68 B	37.15%
MRK	36.33	7.07	19.45%	2.56%	$324.61 B	13.59%
AZN	25.14	5.51	21.93%	1.90%	$261.15 B	17.19%
GILD	17.54	6.90	39.33%	2.47%	$161.64 B	30.99%
BMY	17.28	6.25	36.19%	4.05%	$125.69 B	15.01%
ZTS	11.99	9.80	81.75%	2.74%	$31.69 B	27.79%
REGN	15.66	2.20	14.08%	0.55%	$69.27 B	29.65%
HALO	27.62	43.86	158.82%	0.00%	$9.63 B	23.13%
AMGN	26.05	22.11	84.87%	2.60%	$203.18 B	20.96%
MCK	21.59	-123.30	-570.98%	0.39%	$102.83 B	1.18%
VRTX	28.04	6.28	22.41%	0.00%	$121.66 B	35.51%
CAH	34.58	-20.13	-58.20%	0.89%	$53.78 B	0.62%
HRMY	14.10	2.26	16.00%	0.00%	$2.05 B	16.20%
BIIB	21.68	1.59	7.36%	0.00%	$29.75 B	13.81%
MEDP	34.42	38.99	113.29%	0.00%	$16.92 B	17.67%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARWR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (6 people)

United States

37 years

Founded: 1989

1997

Time since IPO - 29 years

232

Employees

Arrowhead Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $12.19 billion, with shareholders equity totaling $598.92 million.

The company employs approximately 232 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Arrowhead Pharmaceuticals Inc. reported $622.01 million in revenue, generating net income of $-300.91 million.

Key financial metrics include a P/E ratio of -40.50, a price-to-book (P/B) ratio of 20.35, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARWR.

Market cap

$12.19 billion

Net worth

$598.92 million

$598,920,000.00

Assets

$2.27 billion

$2,268,260,000.00

Total Shares Outstanding

142.00 million

142,000,000

Average Daily Trading Volume

$2.31 million

$2,309,936.00

Sector

Health Care

Industry

Biotechnology

ARWR

ARWR revenue and profits

Financial Results ARWR

DRAG THE FRAME TO SEE MORE DATA

ARWR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$855.08 20,75% (12M)

P/E

21.59

0.39%

ROE

-570.98%

P/BV

-123.30

CAH - Cardinal Health

$230.27 48,08% (12M)

P/E

34.58

0.89%

ROE

-58.20%

P/BV

-20.13

JNJ - Johnson & Johnson

$267.58 63,82% (12M)

P/E

30.06

1.99%

ROE

24.76%

P/BV

7.44

MRK - Merck & Co.

$131.89 60,86% (12M)

P/E

36.33

2.56%

ROE

19.45%

P/BV

7.07

AZN - AstraZeneca

$170.63 20,86% (12M)

P/E

25.14

1.90%

ROE

21.93%

P/BV

5.51

ABBV - AbbVie

$260.03 42,23% (12M)

P/E

126.05

2.60%

ROE

-54.98%

P/BV

-69.30

NVO - Novo Nordisk

$49.48 --24,82% (12M)

P/E

11.48

3.79%

ROE

60.40%

P/BV

6.93

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$855.08 20,75% (12 M)

P/L

21.59

0.39%

ROE

-570.98%

P/VP

-123.30

CAH - Cardinal Health

$230.27 48,08% (12 M)

P/L

34.58

0.89%

ROE

-58.20%

P/VP

-20.13

JNJ - Johnson & Johnson

$267.58 63,82% (12 M)

P/L

30.06

1.99%

ROE

24.76%

P/VP

7.44

MRK - Merck & Co.

$131.89 60,86% (12 M)

P/L

36.33

2.56%

ROE

19.45%

P/VP

7.07

AZN - AstraZeneca

$170.63 20,86% (12 M)

P/L

25.14

1.90%

ROE

21.93%

P/VP

5.51

ABBV - AbbVie

$260.03 42,23% (12 M)

P/L

126.05

2.60%

ROE

-54.98%

P/VP

-69.30

NVO - Novo Nordisk

$49.48 --24,82% (12 M)

P/L

11.48

3.79%

ROE

60.40%

P/VP

6.93

Frequently Asked Questions

What is the price of Arrowhead Pharmaceuticals (ARWR) today?

A cotação de Arrowhead Pharmaceuticals (ARWR) hoje está em US$ 86.67, com uma variação de 450.6% em relação ao último ano. A cotação de Arrowhead Pharmaceuticals (ARWR) iniciou o ano negociando na casa dos US$ 66.39 e hoje está em US$ 86.67. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Arrowhead Pharmaceuticals (ARWR) e dados de ações do Ibovespa e mercados internacionais.

Quando Arrowhead Pharmaceuticals (ARWR) paga dividendos?

Arrowhead Pharmaceuticals (ARWR) não distribuiu dividendos no último ano.

Is Arrowhead Pharmaceuticals (ARWR) a good investment?

Atualmente, Arrowhead Pharmaceuticals (ARWR) está cotada a US$ 86.67, com um P/L de -40.50, representando um desvio de -749% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 450.6 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 450.60%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Arrowhead Pharmaceuticals (ARWR) stock?

Investir em ações de Arrowhead Pharmaceuticals (ARWR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Arrowhead Pharmaceuticals (ARWR) yield today?

A rentabilidade de Arrowhead Pharmaceuticals (ARWR) foi de 9.86% no último mês, 450.60% no último ano e 26.76% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Arrowhead Pharmaceuticals (ARWR) hoje, o investimento total seria de US$ 8,666.50, com base na cotação atual de US$ 86.67.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 47,717.75
Em 5 anos: US$ 10,985.66
Em 10 anos: US$ 126,020.44

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARWR

Arrowhead Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARWR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals Inc.

United States

37 years

1997

232

PROFIT X PRICE ARWR

Financial Results ARWR

ARWR cash flow

Asset, Revenue and Profit Growth - ARWR

ARWR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions